Definium Therapeutics, Inc. · NASDAQ:DFTX
Roberts Brandi sold 3,377 Definium Therapeutics, Inc. shares (Form 4)
Traded Sep 25, 2026 · Filed Sep 29, 2026
On Sep 25, 2026, Roberts Brandi (Chief Financial Officer) sold 3,377 Definium Therapeutics, Inc. shares at US$36.57 for US$123K under a trading plan, leaving 394,528 shares. Filed Sep 29, 2026 (Form 4).
- Sold
- 3,377 shares
- Price
- US$36.57
- Value
- US$123K
- Holding after
- 394,528 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Common Shares | Sale | 3,377 | US$36.57 | 394,528 | Direct |
Source
Related
- Definium Therapeutics, Inc.
- Roberts Brandi
- Definium Therapeutics, Inc. shareholders
- Form 4 · Roberts Brandi · Sep 14, 2026
- Form 4 · Roberts Brandi · Aug 12, 2026
- Form 4 · Roberts Brandi · Jun 26, 2026
- Form 4 · Roberts Brandi · Jun 22, 2026
- Form 4 · Karlin Daniel · Sep 29, 2026
- Form 4 · Barrow Robert · Sep 29, 2026
- Form 4 · Wiley Matthew T. · Sep 29, 2026
- Form 4 · Sullivan Mark · Sep 29, 2026
- Form 4 · Krebs Andreas · Sep 18, 2026